Jamjoom Pharma raised its EBITDA marginoutlook for 2025

Jamjoom Pharma reviews 2025 guidance

23/10/2025 Argaam Special

Jamjoom Pharma raised its EBITDA margin outlook for 2025 Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) revised its 2025 str

To Access this Content, Please Login Or Register

To Access this Content, Please Login or Subscribe

Most Read